SMAD-4 cooperates with TGF-β to enhance PTEN expression upon the inhibition of RAS/ERK pathway in gastric carcinoma cells

Progress in Biochemistry and Biophysics

Volumn 38, Issue 6, 2011, Pages 543-550

  Ammar, Matloob ^a   Pan, Lina ^b   Hong, Pan ^a   Lu, Jun ^a   Huang, Baiqu ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

^b TIANJIN NORMAL UNIVERSITY   (China)

Author keywords

PTEN; RAS ERK; SMAD 4; TGF 1

Indexed keywords

EID: 79960270982     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2010.00534     Document Type: Article

References (31)

1. Massague J. TGFbeta in Cancer. Cell, 2008, 134 (2):215-230.
2. Yang L, Moses HL. Transforming growth factor beta: tumor suppressor or promoter? Are host immune cells the answer? Cancer research, 2008, 68 (22):9107-9111.
3. Aoki C A, Borchers A T, Li M, Flavell R A, Bowlus C L, Ansari A A, Gershwin M E. Transforming growth factor beta (TGF-beta) and autoimmunity. Autoimmun Rev, 2005, 4 (7):450-459. (Pubitemid 41219324)
4. Kano M R, Bae Y, Iwata C, Morishita Y, Yashiro M, Oka M, Fujii T, Komuro A, Kiyono K, Kaminishi M et al, Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signaling. Proc Natl Acad Sci U S A, 2007, 104 (9):3460-3465. (Pubitemid 46364181)
5. Massague J, Seoane J, Wotton D, Smad transcription factors. Genes Dev 2005, 19 (23):2783-2810. (Pubitemid 41739965)
6. Derynck R, Zhang Y E, Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature, 2003, 425(6958):577-584. (Pubitemid 37280136)
7. Kloos D U, Choi C, Wingender E. The TGF-beta - Smad network: introducing bioinformatic tools. Trends Genet, 2002, 18 (2):96-103. (Pubitemid 34127809)
8. Derynck R, Akhurst R J, Balmain A, TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001, 29 (2):117-129. (Pubitemid 32952643)
9. Wrana J L. Crossing Smads. Sci STKE, 2000, 2000 (23): re1.
10. Hahn S A, Schutte M, Hoque A T, Moskaluk C A, da Costa L T, Rozenblum E, Weinstein C L, Fischer A, Yeo C J, Hruban R H, Kern S E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science, 1996, 271 (5247):350-353.
11. Wilentz R E, Iacobuzio-Donahue C A, Argani P, McCarthy D M, Parsons J L, Yeo C J, Kern S E, Hruban R H. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res, 2000, 60 (7):2002-2006. (Pubitemid 30207663)
12. Natsugoe S, Xiangming C, Matsumoto M, Okumura H, Nakashima S, Sakita H, Ishigami S, Baba M, Takao S, Aikou T. Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus. Clin Cancer Res, 2002, 8 (6):1838-1842. (Pubitemid 34633743)
13. Salovaara R, Roth S, Loukola A, Launonen V, Sistonen P, Avizienyte E, Kristo P, Jarvinen H, Souchelnytskyi S, Sarlomo-Rikala M, Aaltonen L A. Frequent loss of SMAD4/DPC4 protein in colorectal cancers. Gut, 2002, 51 (1):56-59. (Pubitemid 34717744)
14. Cardillo M R, Lazzereschi D, Gandini O, Di Silverio F, Colletta G. Transforming growth factor-beta pathway in human renal cell carcinoma and surrounding normal-appearing renal parenchyma. Anal Quant Cytol Histol, 2001, 23 (2):109-117. (Pubitemid 32378082)
15. Xie W, Mertens J C, Reiss D J, Rimm D L, Camp R L, Haffty B G, Reiss M, Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study. Cancer Res 2002, 62 (2):497-505. (Pubitemid 34106424)
16. Schutte M, Hruban R H, Hedrick L, Cho K R, Nadasdy G M, Weinstein C L, Bova G S, Isaacs W B, Cairns P, Nawroz H, Sidransky D, Casero R A, Jr., Meltzer P S, Hahn S A, Kern S E. DPC4 gene in various tumor types. Cancer Res, 1996, 56 (11):2527-2530.
17. Kranenburg O. The KRAS oncogene: past, present, and future. Biochim Biophys Acta, 2005, 1756 (2):81-82. (Pubitemid 41773135)
18. Brink M, de Goeij A F, Weijenberg M P, Roemen G M, Lentjes M H, Pachen M M, Smits K M, de Bruine A P, Goldbohm R A, van den Brandt P A. K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study. Carcinogenesis, 2003, 24 (4):703-710. (Pubitemid 36592405)
19. Laghi L, Orbetegli O, Bianchi P, Zerbi A, Di Carlo V, Boland C R, Malesci A. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers. Oncogene, 2002, 21 (27):4301-4306. (Pubitemid 34753836)
20. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang S I, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner S H, Giovanella B C, Ittmann M, Tycko B, Hibshoosh H, Wigler M H, Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 1997, 275 (5308):1943-1947. (Pubitemid 27148818)
21. Steck P A, Pershouse M A, Jasser S A, Yung W K, Lin H, Ligon A H, Langford L A, Baumgard M L, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng D H, Tavtigian S V. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet, 1997, 15 (4):356-362. (Pubitemid 27147102)
22. Myers M P, Stolarov J P, Eng C, Li J, Wang S I, Wigler M H, Parsons R, Tonks N K. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci U S A, 1997, 94 (17):9052-9057.
23. Vivanco I, Sawyers C L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer, 2002, 2 (7):489-501. (Pubitemid 37328931)
24. Sansal I, Sellers W R. The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol, 2004, 22 (14):2954-2963. (Pubitemid 41079915)
25. Yang L, Kuang L G, Zheng H C, Li J Y, Wu D Y, Zhang S M, Xin Y. PTEN encoding product: a marker for tumorigenesis and progression of gastric carcinoma. World J Gastroenterol, 2003, 9 (1):35-39. (Pubitemid 36131274)
26. Li Y L, Tian Z, Wu D Y, Fu B Y, Xin Y. Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions. World J Gastroenterol, 2005, 11 (2):285-288. (Pubitemid 40125221)
27. Chow J Y, Quach K T, Cabrera B L, Cabral J A, Beck S E, Carethers JM. RAS/ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells. Carcinogenesis, 2007, 28 (11):2321-2327. (Pubitemid 350111590)
28. Chow J Y, Quach K T, Cabrera B L, Cabral J A, Beck S E, Carethers J M. RAS/ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells. Carcinogenesis, 2007, 28 (11):2321-2327. (Pubitemid 350111590)
29. Inman G J. Linking Smads and transcriptional activation. Biochem J, 2005, 386 (Pt 1):e1-e3.
30. Mita H, Toyota M, Aoki F, Akashi H, Maruyama R, Sasaki Y, Suzuki H, Idogawa M, Kashima L, Yanagihara K, Fujita M, Hosokawa M, Kusano M, Sabau S V, Tatsumi H, Imai K, Shinomura Y, Tokino T. A novel method, digital genome scanning detects KRAS gene amplification in gastric cancers: involvement of overexpressed wild-type KRAS in downstream signaling and cancer cell growth. BMC Cancer, 2009, 9:198.
31. Liu Z M, Liu L N, Li M, Zhang Q P, Cheng S H, Lu S. Mutation detection of KRAS by high-resolution melting analysis in Chinese with gastric cancer. Oncol Rep, 2009, 22 (3):515-520.